Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2009 Filed Nov 23, 2009 22:35 UTC |
KOHAN RAUL EExe V-P & Pres, Animal Health
|
GrantCommon Stock | 20,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-022760 · doc4.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,182 F1 · shares: The acquisition of the shares was subject to the achievement of performance goals approved by the Compensation Committee of the Issuer. The shares will become payable on December 31, 2011 provided that the reporting person remains continuously employed by the Issuer through that date, or, if sooner, upon the reporting person's involuntary termination of employment other than for cause. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
CHEELEY C RONSenior Vice President
|
Disposition to issuerPhantom Stock Unit · Derivative | 67,062.69 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 10 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 67,062.69 shares Expires not disclosed F5 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F6 · price: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. F6 · derivative.exercise_date: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. F6 · derivative.expiration_date: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
CHEELEY C RONSenior Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 116,500 | Not disclosed Strike: $22.91 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 9 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 116,500 shares Expires 2016-04-30 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
CHEELEY C RONSenior Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 110,000 | Not disclosed Strike: $18.85 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 8 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 110,000 shares Expires 2015-04-30 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
CHEELEY C RONSenior Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 179,362 | Not disclosed Strike: $20.70 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 7 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 179,362 shares Expires 2015-04-24 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
CHEELEY C RONSenior Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 150,000 | Not disclosed Strike: $31.57 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 6 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 150,000 shares Expires 2014-04-30 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
CHEELEY C RONSenior Vice President
|
Disposition to issuerOption (Right to Buy) · Derivative | 74,173 | Not disclosed Strike: $18.20 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 5 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 74,173 shares Expires 2014-02-22 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
CHEELEY C RONSenior Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 30,000 | Not disclosed Strike: $16.62 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 4 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 30,000 shares Expires 2013-07-31 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
CHEELEY C RONSenior Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 180,000 | Not disclosed Strike: $19.23 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 3 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 180,000 shares Expires 2013-05-18 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
CHEELEY C RONSenior Vice President
|
Disposition to issuerCommon Shares | 646.71 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · nonDerivative · entry 2 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 0 F2 · price: In connection with the Merger, each share held in the Issuer's stock fund of the Issuer's 401(k) plan was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Both the shares and cash will remain in the plan until such time as the reporting person elects a distribution therefrom. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
CHEELEY C RONSenior Vice President
|
Disposition to issuerCommon Shares | 49,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · nonDerivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
BERTOLINI ROBERT JExecutive Vice President
|
Disposition to issuerPhantom Stock Unit · Derivative | 65,587.15 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051068 · c91850_4x1.xml · derivative · entry 10 BERTOLINI ROBERT J · CIK 0001270263 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 65,587.15 shares Expires not disclosed F5 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F6 · price: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. F6 · derivative.exercise_date: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. F6 · derivative.expiration_date: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
BERTOLINI ROBERT JExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 264,600 | Not disclosed Strike: $22.91 | Not disclosed |
DisclosureSEC source: 0001209191-09-051068 · c91850_4x1.xml · derivative · entry 9 BERTOLINI ROBERT J · CIK 0001270263 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 264,600 shares Expires 2016-04-30 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
BERTOLINI ROBERT JExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 260,000 | Not disclosed Strike: $18.85 | Not disclosed |
DisclosureSEC source: 0001209191-09-051068 · c91850_4x1.xml · derivative · entry 8 BERTOLINI ROBERT J · CIK 0001270263 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 260,000 shares Expires 2015-04-30 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
BERTOLINI ROBERT JExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 250,000 | Not disclosed Strike: $20.70 | Not disclosed |
DisclosureSEC source: 0001209191-09-051068 · c91850_4x1.xml · derivative · entry 7 BERTOLINI ROBERT J · CIK 0001270263 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 250,000 shares Expires 2015-04-24 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
BERTOLINI ROBERT JExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 345,000 | Not disclosed Strike: $31.57 | Not disclosed |
DisclosureSEC source: 0001209191-09-051068 · c91850_4x1.xml · derivative · entry 6 BERTOLINI ROBERT J · CIK 0001270263 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 345,000 shares Expires 2014-04-30 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
BERTOLINI ROBERT JExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 250,000 | Not disclosed Strike: $18.20 | Not disclosed |
DisclosureSEC source: 0001209191-09-051068 · c91850_4x1.xml · derivative · entry 5 BERTOLINI ROBERT J · CIK 0001270263 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 250,000 shares Expires 2014-02-22 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
BERTOLINI ROBERT JExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 350,000 | Not disclosed Strike: $15.87 | Not disclosed |
DisclosureSEC source: 0001209191-09-051068 · c91850_4x1.xml · derivative · entry 4 BERTOLINI ROBERT J · CIK 0001270263 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 350,000 shares Expires 2013-11-16 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
BERTOLINI ROBERT JExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 240,000 | Not disclosed Strike: $19.23 | Not disclosed |
DisclosureSEC source: 0001209191-09-051068 · c91850_4x1.xml · derivative · entry 3 BERTOLINI ROBERT J · CIK 0001270263 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 240,000 shares Expires 2013-05-18 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
BERTOLINI ROBERT JExecutive Vice President
|
Disposition to issuerCommon Shares | 6,099.41 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051068 · c91850_4x1.xml · nonDerivative · entry 2 BERTOLINI ROBERT J · CIK 0001270263 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 0 F2 · price: In connection with the Merger, each share held in the Issuer's stock fund of the Issuer's 401(k) plan was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Both the shares and cash will remain in the plan until such time as the reporting person elects a distribution therefrom. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC |
BERTOLINI ROBERT JExecutive Vice President
|
Disposition to issuerCommon Shares | 104,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051068 · c91850_4x1.xml · nonDerivative · entry 1 BERTOLINI ROBERT J · CIK 0001270263 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Hassan FredDirector · Chairman and CEO
|
Disposition to issuerPhantom Stock Unit · Derivative | 196,761.57 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051069 · c91852_4x1.xml · derivative · entry 9 HASSAN FRED · CIK 0001110744 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 196,761.57 shares Expires not disclosed F4 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F5 · price: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. F5 · derivative.exercise_date: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. F5 · derivative.expiration_date: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Hassan FredDirector · Chairman and CEO
|
Disposition to issuerOption (right to buy) · Derivative | 868,300 | Not disclosed Strike: $22.91 | Not disclosed |
DisclosureSEC source: 0001209191-09-051069 · c91852_4x1.xml · derivative · entry 8 HASSAN FRED · CIK 0001110744 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 868,300 shares Expires 2016-04-30 F3 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Hassan FredDirector · Chairman and CEO
|
Disposition to issuerOption (right to buy) · Derivative | 836,000 | Not disclosed Strike: $18.85 | Not disclosed |
DisclosureSEC source: 0001209191-09-051069 · c91852_4x1.xml · derivative · entry 7 HASSAN FRED · CIK 0001110744 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 836,000 shares Expires 2015-04-30 F3 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Hassan FredDirector · Chairman and CEO
|
Disposition to issuerOption (right to buy) · Derivative | 1,100,000 | Not disclosed Strike: $20.70 | Not disclosed |
DisclosureSEC source: 0001209191-09-051069 · c91852_4x1.xml · derivative · entry 6 HASSAN FRED · CIK 0001110744 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,100,000 shares Expires 2015-04-24 F3 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Hassan FredDirector · Chairman and CEO
|
Disposition to issuerOption (right to buy) · Derivative | 1,180,000 | Not disclosed Strike: $31.57 | Not disclosed |
DisclosureSEC source: 0001209191-09-051069 · c91852_4x1.xml · derivative · entry 5 HASSAN FRED · CIK 0001110744 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,180,000 shares Expires 2014-04-30 F3 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Hassan FredDirector · Chairman and CEO
|
Disposition to issuerOption (Right to Buy) · Derivative | 1,100,000 | Not disclosed Strike: $18.20 | Not disclosed |
DisclosureSEC source: 0001209191-09-051069 · c91852_4x1.xml · derivative · entry 4 HASSAN FRED · CIK 0001110744 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,100,000 shares Expires 2014-02-22 F3 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Hassan FredDirector · Chairman and CEO
|
Disposition to issuerOption (right to buy) · Derivative | 1,000,000 | Not disclosed Strike: $19.23 | Not disclosed |
DisclosureSEC source: 0001209191-09-051069 · c91852_4x1.xml · derivative · entry 3 HASSAN FRED · CIK 0001110744 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,000,000 shares Expires 2013-05-18 F3 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Hassan FredDirector · Chairman and CEO
|
Disposition to issuerOption (right to buy) · Derivative | 900,000 | Not disclosed Strike: $17.43 | Not disclosed |
DisclosureSEC source: 0001209191-09-051069 · c91852_4x1.xml · derivative · entry 2 HASSAN FRED · CIK 0001110744 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 900,000 shares Expires 2013-04-19 F3 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Hassan FredDirector · Chairman and CEO
|
Disposition to issuerCommon Shares | 935,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051069 · c91852_4x1.xml · nonDerivative · entry 1 HASSAN FRED · CIK 0001110744 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Koestler Thomas PExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 209,700 | Not disclosed Strike: $22.91 | Not disclosed |
DisclosureSEC source: 0001209191-09-051070 · c91879_4x1.xml · derivative · entry 9 Koestler Thomas P · CIK 0001373605 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 209,700 shares Expires 2016-04-30 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Koestler Thomas PExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 220,000 | Not disclosed Strike: $18.85 | Not disclosed |
DisclosureSEC source: 0001209191-09-051070 · c91879_4x1.xml · derivative · entry 8 Koestler Thomas P · CIK 0001373605 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 220,000 shares Expires 2015-04-30 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Koestler Thomas PExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 100,000 | Not disclosed Strike: $20.70 | Not disclosed |
DisclosureSEC source: 0001209191-09-051070 · c91879_4x1.xml · derivative · entry 7 Koestler Thomas P · CIK 0001373605 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 100,000 shares Expires 2015-04-24 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Koestler Thomas PExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 240,000 | Not disclosed Strike: $31.57 | Not disclosed |
DisclosureSEC source: 0001209191-09-051070 · c91879_4x1.xml · derivative · entry 6 Koestler Thomas P · CIK 0001373605 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 240,000 shares Expires 2014-04-30 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Koestler Thomas PExecutive Vice President
|
Disposition to issuerOption (Right to Buy) · Derivative | 70,000 | Not disclosed Strike: $18.20 | Not disclosed |
DisclosureSEC source: 0001209191-09-051070 · c91879_4x1.xml · derivative · entry 5 Koestler Thomas P · CIK 0001373605 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 70,000 shares Expires 2014-02-22 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Koestler Thomas PExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 150,000 | Not disclosed Strike: $16.12 | Not disclosed |
DisclosureSEC source: 0001209191-09-051070 · c91879_4x1.xml · derivative · entry 4 Koestler Thomas P · CIK 0001373605 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 150,000 shares Expires 2013-08-17 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Koestler Thomas PExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 90,000 | Not disclosed Strike: $19.23 | Not disclosed |
DisclosureSEC source: 0001209191-09-051070 · c91879_4x1.xml · derivative · entry 3 Koestler Thomas P · CIK 0001373605 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 90,000 shares Expires 2013-05-18 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Koestler Thomas PExecutive Vice President
|
Disposition to issuerDeferred Stock Unit Award · Derivative | 75,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001209191-09-051070 · c91879_4x1.xml · derivative · entry 2 Koestler Thomas P · CIK 0001373605 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 75,000 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit ("DSU") is the economic equivalent of one share of common stock. F4 · price: In connection with the Merger, the cash value of the DSU's will be paid to the reporting person in accordance with the terms of the Issuer's 2006 Stock Incentive Plan. F3 · derivative.exercise_date: The DSU's became vested upon the closing of the Merger. F4 · derivative.expiration_date: In connection with the Merger, the cash value of the DSU's will be paid to the reporting person in accordance with the terms of the Issuer's 2006 Stock Incentive Plan. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:53 UTC |
Koestler Thomas PExecutive Vice President
|
Disposition to issuerCommon Shares | 59,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051070 · c91879_4x1.xml · nonDerivative · entry 1 Koestler Thomas P · CIK 0001373605 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC |
KOEHLER STEVEN HVice President and Controller
|
Disposition to issuerOption (right to buy) · Derivative | 57,300 | Not disclosed Strike: $22.91 | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · derivative · entry 7 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 57,300 shares Expires 2016-04-30 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC |
KOEHLER STEVEN HVice President and Controller
|
Disposition to issuerOption (right to buy) · Derivative | 58,000 | Not disclosed Strike: $18.85 | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · derivative · entry 6 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 58,000 shares Expires 2015-04-30 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC |
KOEHLER STEVEN HVice President and Controller
|
Disposition to issuerOption (right to buy) · Derivative | 80,000 | Not disclosed Strike: $31.57 | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · derivative · entry 5 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 80,000 shares Expires 2014-04-30 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC |
KOEHLER STEVEN HVice President and Controller
|
Disposition to issuerOption (right to buy) · Derivative | 50,000 | Not disclosed Strike: $19.23 | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · derivative · entry 4 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 50,000 shares Expires 2013-05-18 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC |
KOEHLER STEVEN HVice President and Controller
|
Disposition to issuerOption (right to buy) · Derivative | 75,000 | Not disclosed Strike: $19.33 | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · derivative · entry 3 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 75,000 shares Expires 2013-03-19 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC |
KOEHLER STEVEN HVice President and Controller
|
Disposition to issuerDeferred Stock Unit Award · Derivative | 20,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · derivative · entry 2 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit ("DSU") is the economic equivalent of one share of common stock. F4 · price: In connection with the Merger, the DSU's will be paid to the reporting person in accordance with the terms of the Issuer's 2006 Stock Incentive Plan. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, upon closing of the Merger, the DSU's were converted into DSU's over common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F4 · derivative.expiration_date: In connection with the Merger, the DSU's will be paid to the reporting person in accordance with the terms of the Issuer's 2006 Stock Incentive Plan. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC |
KOEHLER STEVEN HVice President and Controller
|
Disposition to issuerCommon Shares | 10,619 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · nonDerivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:56 UTC |
COX CARRIE SMITHExecutive Vice President
|
Disposition to issuerPhantom Stock Unit · Derivative | 66,552.22 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051073 · c91877_4x1.xml · derivative · entry 7 COX CARRIE SMITH · CIK 0001110753 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 66,552.22 shares Expires not disclosed F4 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F5 · price: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. F5 · derivative.exercise_date: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. F5 · derivative.expiration_date: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:56 UTC |
COX CARRIE SMITHExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 264,600 | Not disclosed Strike: $22.91 | Not disclosed |
DisclosureSEC source: 0001209191-09-051073 · c91877_4x1.xml · derivative · entry 6 COX CARRIE SMITH · CIK 0001110753 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 264,600 shares Expires 2016-04-30 F3 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:56 UTC |
COX CARRIE SMITHExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 270,000 | Not disclosed Strike: $18.85 | Not disclosed |
DisclosureSEC source: 0001209191-09-051073 · c91877_4x1.xml · derivative · entry 5 COX CARRIE SMITH · CIK 0001110753 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 270,000 shares Expires 2015-04-30 F3 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:56 UTC |
COX CARRIE SMITHExecutive Vice President
|
Disposition to issuerOption (right to buy) · Derivative | 400,000 | Not disclosed Strike: $20.70 | Not disclosed |
DisclosureSEC source: 0001209191-09-051073 · c91877_4x1.xml · derivative · entry 4 COX CARRIE SMITH · CIK 0001110753 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 400,000 shares Expires 2015-04-24 F3 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.